【作用特点】本品为安妥明的衍生物,实验和临床研究表明其作用较安妥明为强,是目前较为理想而有效的降脂药物。药理试验表明,本品对实验大鼠血清总胆固醇的影响不大,给药2周后仅降低17.25％,但高密度脂蛋白胆固醇的 【Features】 This product is a derivative of clofibrate, experimental and clinical studies have shown that its role is stronger than clofibrate, is the more ideal and effective lipid-lowering drugs. Pharmacological tests show that the product of the experimental rat serum total cholesterol little effect, only 2 weeks after administration decreased by 17.25%, but the high-density lipoprotein cholesterol